You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Flu Shots Industry Research Report, Growth Trends and Competitive Analysis 2021-2027


The global Flu Shots market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Flu Shots production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Flu Shots by regions (countries) and by Application.
The global Flu Shots market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Flu Shots market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Flu Shots markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Flu Shots market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Flu Shots market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Flu Shots market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Flu Shots market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Flu Shots market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Flu Shots market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Flu Shots market by each application segment for the same period.
This report includes the following manufacturers:
GSK
SINOVAC
CHANGSHENG
CCBIO
ALEPH BIOMEDICAL
SANOFI
LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
SIOBP
HUALAN BIO
TIANYUAN BIO-PHARMA
VAXTEC
Market Segment by Type
Influenza Virus Split Vaccines
Influenza Virus Subunit Vaccines
Influenza Whole Virus Vaccines
Market Segment by Application
Avian Influenza Virus-A
Avian Influenza Virus-B
Research Methodology
To compile the detailed study of the global Flu Shots market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Flu Shots market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Flu Shots market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Flu Shots Market Size Growth Rate by Type
1.2.2 Influenza Virus Split Vaccines
1.2.3 Influenza Virus Subunit Vaccines
1.2.4 Influenza Whole Virus Vaccines
1.3 Market Segment by Application
1.3.1 Global Flu Shots Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Avian Influenza Virus-A
1.3.3 Avian Influenza Virus-B
1.4 Study Objectives
1.5 Years Considered

2 Market Perspective
2.1 Global Flu Shots Market Size (2016-2027)
2.1.1 Global Flu Shots Revenue (2016-2027)
2.1.2 Global Flu Shots Sales (2016-2027)
2.2 Global Flu Shots Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Flu Shots Sales by Regions (2016-2021)
2.2.2 Global Flu Shots Revenue by Regions (2016-2021)
2.3 Global Flu Shots Market Size Forecast by Region
2.3.1 Global Flu Shots Sales Forecast by Region (2022-2027)
2.3.2 Global Flu Shots Revenue Forecast by Region (2022-2027)
2.4 Global Top Flu Shots Regions (Countries) Ranking by Market Size
2.5 Flu Shots Industry Trends
2.5.1 Flu Shots Market Trends
2.5.2 Flu Shots Market Drivers
2.5.3 Flu Shots Market Challenges
2.5.4 Flu Shots Market Restraints

3 Competitive Landscape by Manufacturers
3.1 Global Top Flu Shots Manufacturers by Sales (2016-2021)
3.1.1 Global Flu Shots Sales by Manufacturers (2016-2021)
3.1.2 Global Flu Shots Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Flu Shots Sales in 2020
3.2 Global Top Manufacturers Flu Shots by Revenue
3.2.1 Global Flu Shots Revenue by Manufacturers (2016-2021)
3.2.2 Top Flu Shots Manufacturers Covered: Ranking by Revenue
3.2.3 Global Flu Shots Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Flu Shots Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Flu Shots as of 2020)
3.4 Global Flu Shots Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Flu Shots Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Flu Shots Market
3.7 Key Manufacturers Flu Shots Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Global Flu Shots Market Size by Type
4.1 Global Flu Shots Historic Market Review by Type (2016-2021)
4.1.1 Global Flu Shots Sales Market Share by Type (2016-2021)
4.1.2 Global Flu Shots Revenue Market Share by Type (2016-2021)
4.1.3 Flu Shots Price by Type (2016-2021)
4.2 Global Flu Shots Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Flu Shots Sales Forecast by Type (2022-2027)
4.2.2 Global Flu Shots Revenue Forecast by Type (2022-2027)
4.2.3 Flu Shots Price Forecast by Type (2022-2027)

5 Global Flu Shots Market Size by Application
5.1 Global Flu Shots Historic Market Review by Application (2016-2021)
5.1.1 Global Flu Shots Sales Market Share by Application (2016-2021)
5.1.2 Global Flu Shots Revenue Market Share by Application (2016-2021)
5.1.3 Flu Shots Price by Application (2016-2021)
5.2 Global Flu Shots Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Flu Shots Sales Forecast by Application (2022-2027)
5.2.2 Global Flu Shots Revenue Forecast by Application (2022-2027)
5.2.3 Flu Shots Price Forecast by Application (2022-2027)

6 North America
6.1 North America Flu Shots Sales Breakdown by Company
6.1.1 North America Flu Shots Sales by Company (2016-2027)
6.1.2 North America Flu Shots Revenue by Company (2016-2027)
6.2 North America Flu Shots Market Size by Type (2016-2027)
6.2.1 North America Flu Shots Sales by Type (2016-2027)
6.2.2 North America Flu Shots Revenue by Type (2016-2027)
6.3 North America Flu Shots Market Size by Application (2016-2027)
6.3.1 North America Flu Shots Sales by Application (2016-2027)
6.3.2 North America Flu Shots Revenue by Application (2016-2027)
6.4 North America Flu Shots Market Size by Country
6.4.1 North America Flu Shots Sales by Country (2016-2027)
6.4.2 North America Flu Shots Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Flu Shots Sales Breakdown by Company
7.1.1 Europe Flu Shots Sales by Company (2016-2027)
7.1.2 Europe Flu Shots Revenue by Company (2016-2027)
7.2 Europe Flu Shots Market Size by Type (2016-2027)
7.2.1 Europe Flu Shots Sales by Type (2016-2027)
7.2.2 Europe Flu Shots Revenue by Type (2016-2027)
7.3 Europe Flu Shots Market Size by Application (2016-2027)
7.3.1 Europe Flu Shots Sales by Application (2016-2027)
7.3.2 Europe Flu Shots Revenue by Application (2016-2027)
7.4 Europe Flu Shots Market Size by Country
7.4.1 Europe Flu Shots Sales by Country (2016-2027)
7.4.2 Europe Flu Shots Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Flu Shots Sales Breakdown by Company
8.1.1 Asia Pacific Flu Shots Sales by Company (2016-2027)
8.1.2 Asia Pacific Flu Shots Revenue by Company (2016-2027)
8.2 Asia Pacific Flu Shots Market Size by Type (2016-2027)
8.2.1 Asia Pacific Flu Shots Sales by Type (2016-2027)
8.2.2 Asia Pacific Flu Shots Revenue by Type (2016-2027)
8.3 Asia Pacific Flu Shots Market Size by Application (2016-2027)
8.3.1 Asia Pacific Flu Shots Sales by Application (2016-2027)
8.3.2 Asia Pacific Flu Shots Revenue by Application (2016-2027)
8.4 Asia Pacific Flu Shots Market Size by Regions
8.4.1 Asia Pacific Flu Shots Sales by Regions
8.4.2 Asia Pacific Flu Shots Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Flu Shots Sales Breakdown by Company
9.1.1 Latin America Flu Shots Sales by Company (2016-2027)
9.1.2 Latin America Flu Shots Revenue by Company (2016-2027)
9.2 Latin America Flu Shots Market Size by Type (2016-2027)
9.2.1 Latin America Flu Shots Sales by Type (2016-2027)
9.2.2 Latin America Flu Shots Revenue by Type (2016-2027)
9.3 Latin America Flu Shots Market Size by Application (2016-2027)
9.3.1 Latin America Flu Shots Sales by Application (2016-2027)
9.3.2 Latin America Flu Shots Revenue by Application (2016-2027)
9.4 Latin America Flu Shots Market Size by Country
9.4.1 Latin America Flu Shots Sales by Country (2016-2027)
9.4.2 Latin America Flu Shots Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Flu Shots Sales Breakdown by Company
10.1.1 Middle East and Africa Flu Shots Sales by Company (2016-2027)
10.1.2 Middle East and Africa Flu Shots Revenue by Company (2016-2027)
10.2 Middle East and Africa Flu Shots Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Flu Shots Sales by Type (2016-2027)
10.2.2 Middle East and Africa Flu Shots Revenue by Type (2016-2027)
10.3 Middle East and Africa Flu Shots Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Flu Shots Sales by Application (2016-2027)
10.3.2 Middle East and Africa Flu Shots Revenue by Application (2016-2027)
10.4 Middle East and Africa Flu Shots Market Size by Country
10.4.1 Middle East and Africa Flu Shots Sales by Country (2016-2027)
10.4.2 Middle East and Africa Flu Shots Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Flu Shots Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 GSK Flu Shots Products and Services
11.1.5 GSK Flu Shots SWOT Analysis
11.1.6 GSK Recent Developments
11.2 SINOVAC
11.2.1 SINOVAC Corporation Information
11.2.2 SINOVAC Overview
11.2.3 SINOVAC Flu Shots Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 SINOVAC Flu Shots Products and Services
11.2.5 SINOVAC Flu Shots SWOT Analysis
11.2.6 SINOVAC Recent Developments
11.3 CHANGSHENG
11.3.1 CHANGSHENG Corporation Information
11.3.2 CHANGSHENG Overview
11.3.3 CHANGSHENG Flu Shots Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 CHANGSHENG Flu Shots Products and Services
11.3.5 CHANGSHENG Flu Shots SWOT Analysis
11.3.6 CHANGSHENG Recent Developments
11.4 CCBIO
11.4.1 CCBIO Corporation Information
11.4.2 CCBIO Overview
11.4.3 CCBIO Flu Shots Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 CCBIO Flu Shots Products and Services
11.4.5 CCBIO Flu Shots SWOT Analysis
11.4.6 CCBIO Recent Developments
11.5 ALEPH BIOMEDICAL
11.5.1 ALEPH BIOMEDICAL Corporation Information
11.5.2 ALEPH BIOMEDICAL Overview
11.5.3 ALEPH BIOMEDICAL Flu Shots Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 ALEPH BIOMEDICAL Flu Shots Products and Services
11.5.5 ALEPH BIOMEDICAL Flu Shots SWOT Analysis
11.5.6 ALEPH BIOMEDICAL Recent Developments
11.6 SANOFI
11.6.1 SANOFI Corporation Information
11.6.2 SANOFI Overview
11.6.3 SANOFI Flu Shots Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 SANOFI Flu Shots Products and Services
11.6.5 SANOFI Flu Shots SWOT Analysis
11.6.6 SANOFI Recent Developments
11.7 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
11.7.1 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Corporation Information
11.7.2 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Overview
11.7.3 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Products and Services
11.7.5 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots SWOT Analysis
11.7.6 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Recent Developments
11.8 SIOBP
11.8.1 SIOBP Corporation Information
11.8.2 SIOBP Overview
11.8.3 SIOBP Flu Shots Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 SIOBP Flu Shots Products and Services
11.8.5 SIOBP Flu Shots SWOT Analysis
11.8.6 SIOBP Recent Developments
11.9 HUALAN BIO
11.9.1 HUALAN BIO Corporation Information
11.9.2 HUALAN BIO Overview
11.9.3 HUALAN BIO Flu Shots Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 HUALAN BIO Flu Shots Products and Services
11.9.5 HUALAN BIO Flu Shots SWOT Analysis
11.9.6 HUALAN BIO Recent Developments
11.10 TIANYUAN BIO-PHARMA
11.10.1 TIANYUAN BIO-PHARMA Corporation Information
11.10.2 TIANYUAN BIO-PHARMA Overview
11.10.3 TIANYUAN BIO-PHARMA Flu Shots Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 TIANYUAN BIO-PHARMA Flu Shots Products and Services
11.10.5 TIANYUAN BIO-PHARMA Flu Shots SWOT Analysis
11.10.6 TIANYUAN BIO-PHARMA Recent Developments
11.11 VAXTEC
11.11.1 VAXTEC Corporation Information
11.11.2 VAXTEC Overview
11.11.3 VAXTEC Flu Shots Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 VAXTEC Flu Shots Products and Services
11.11.5 VAXTEC Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Flu Shots Value Chain Analysis
12.2 Flu Shots Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Flu Shots Production Mode & Process
12.4 Flu Shots Sales and Marketing
12.4.1 Flu Shots Sales Channels
12.4.2 Flu Shots Distributors
12.5 Flu Shots Customers
13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Mar, 2021
  • NO OF PAGES: 105